Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high‐risk patients with diffuse large B‐cell lymphoma

Abramson, Jeremy S. ; Hellmann, Matthew ; Barnes, Jeffrey A. ; Hammerman, Peter ; Toomey, Christiana ; Takvorian, Tak ; Muzikansky, Alona ; Hochberg, Ephraim P.

Cancer, 2010-09, Vol.116 (18), p.4283-4290 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível